Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sodium Picosulfate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 406Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hetero Drugs Generic Citric Acid;Magnesium Oxide Receives Approval in the U.S.
    Hetero Drugs Generic Citric Acid;Magnesium Oxide Receives Approval in the U.S.

    18 Jul 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212789

    FDA
    18 Jul 2022
    Share Share
    New restrictions introduced on sales of stimulant laxatives to counter risk
    New restrictions introduced on sales of stimulant laxatives to counter risk

    18 Aug 2020

    // GOV

    https://www.gov.uk/government/news/new-restrictions-introduced-on-sales-of-stimulant-laxatives-to-counter-risks-from-overuse

    GOV
    18 Aug 2020
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Clenpiq 209589 (Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid ) Oral Solution 10 mg, 3.5 g, and 12 g
    FDA Confirms Paragraph IV Patent Challenge of Clenpiq 209589 (Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid ) Oral Solution 10 mg, 3.5 g, and 12 g

    11 Apr 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-clenpiq-209589-sodium-picosulfate-magnesium-oxide-and-anhydrous-citric-acid-oral-solution-10-mg-35-g-and-12-g-1554960365.pdf

    FDA
    11 Apr 2019
    Share Share
    Ferring's CLENPIQ™ (sodium picosulfate, magnesium oxide & anhydrous citric acid)
    Ferring's CLENPIQ™ (sodium picosulfate, magnesium oxide & anhydrous citric acid)

    12 Feb 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ferrings-clenpiq-sodium-picosulfate-magnesium-oxide-and-anhydrous-citric-acid-oral-solution-for-colonoscopy-prep-now-available-300596614.html

    PR NEWSWIRE
    12 Feb 2018
    Share Share
    FDA Approves Ferring's CLENPIQ™sodium picosulfate, MgOH, & anhydrous citric acid
    FDA Approves Ferring's CLENPIQ™sodium picosulfate, MgOH, & anhydrous citric acid

    30 Nov 2017

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-approves-ferrings-clenpiq-sodium-picosulfate-magnesium-oxide-and-anhydrous-citric-acid-oral-solution-for-colonoscopy-prep-300563466.html

    PR NEWSWIRE
    30 Nov 2017
    Share Share
    Par's Generic Sodium Picosulfate; Magnesium Oxide Receives Tentative Approval In US
    Par's Generic Sodium Picosulfate; Magnesium Oxide Receives Tentative Approval In US

    21 Nov 2016

    // FDA

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205743

    FDA
    21 Nov 2016
    Share Share